Kolleen T. Kennedy

2018

In 2018, Kolleen T. Kennedy earned a total compensation of $3.9M as Executive Vice President and President, Oncology Systems at Varian, a 19% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$1,126,538
Option Awards$420,000
Salary$684,899
Stock Awards$1,680,000
Other$22,530
Total$3,933,967

Kennedy received $1.7M in stock awards, accounting for 43% of the total pay in 2018.

Kennedy also received $1.1M in non-equity incentive plan, $420K in option awards, $684.9K in salary and $22.5K in other compensation.

Rankings

In 2018, Kolleen T. Kennedy's compensation ranked 2,843rd out of 14,244 executives tracked by ExecPay. In other words, Kennedy earned more than 80.0% of executives.

ClassificationRankingPercentile
All
2,843
out of 14,244
80th
Division
Manufacturing
1,051
out of 5,759
82nd
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
123
out of 849
86th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
60
out of 547
89th
Industry
Electromedical and Electrotherapeutic Apparatus
11
out of 77
86th
Source: SEC filing on December 21, 2018.

Kennedy's colleagues

We found three more compensation records of executives who worked with Kolleen T. Kennedy at Varian in 2018.

2018

Dow Wilson

Varian

Chief Executive Officer

2018

Gary Bischoping

Varian

Chief Financial Officer

2018

John Kuo

Varian

General Counsel

News

You may also like